The Health Communications Core (HCC) provides interdisciplinary support to University of Michigan Comprehensive Cancer Center (UMCCC) Investigators In the design, development, and delivery of research interventions requiring targeted and tailored communications across the continuum of cancer care. The Core provides scientific expertise regarding tailored health communication, individual counseling, intervention design, study protocols, and the development of evaluation instruments;behavioral science expertise and tailored content development;technical engineering and programming, including web, print, mobile device, social media;creative media design and development. Including graphic design, illustration, animation, photography, audio engineering, video production, music composition, and advanced web programming;activities in support of data collection, management, and reporting;assistance in the planning of analyses, interpretation of results, and presentation and publication of research findings;and all aspects of project management. Rapid change in the national and global Information technology landscape has created the unprecedented opportunity and critical need for interactive health communications strategies that can be tailored to the specific health needs of the individual and of special populations. In developing a broad spectrum of interactive health communications interventions for investigators conducting cancer prevention, cancer control, and clinical and translational research, the Health Communications Core (HCC) supports multiple facets of the overall research mission of the University of Michigan Comprehensive Cancer Center (UMCCC). The primary aim of the HCC is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications research programs. Achieving this aim depends on the HCC's organization, staff, and Interactions with UMCCC Investigators. Organizing the multidisciplinary staff and technical resources into a unified, cooperative Core allows the HCC to develop and Implement Interventions In a more effective, efficient manner. This core institutionalizes a long-standing commitment of the University of Michigan's Center for Health Communications Research (CHCR) to provide a robust communications resource for all Cancer Center investigators. The HCC plans significant Interactions with other UMCCC Cores, particularly the proposed Patient and Population Sciences Core, the Cancer Informatics Core, and the Biostatistics Core.

Public Health Relevance

The primary aim of the Core is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications programs. Rapid change In the national and global information technology landscape has created the unprecedented opportunity and critical need for interactive health communications Strategies that can be tailored to the specific health needs of the Individual and of special populations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-25
Application #
8559880
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
25
Fiscal Year
2013
Total Cost
$91,674
Indirect Cost
$39,016
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Kim, Yeung-Hyen; Zhu, Lingqiao; Pyaram, Kalyani et al. (2018) PLZF-expressing CD4 T cells show the characteristics of terminally differentiated effector memory CD4 T cells in humans. Eur J Immunol 48:1255-1257
Davis, Elizabeth J; Griffith, Kent A; Kim, Edward J et al. (2018) A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers. Am J Clin Oncol 41:128-132
Mendiratta-Lala, Mishal; Masch, William; Shankar, Prasad R et al. (2018) MR Imaging Evaluation of Hepatocellular Carcinoma Treated with Stereotactic Body Radiation Therapy (SBRT): Long Term Imaging Follow-Up. Int J Radiat Oncol Biol Phys :
Tamura, Shuzo; Wang, Yin; Veeneman, Brendan et al. (2018) Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer 4:77-90
Rosselli-Murai, Luciana K; Yates, Joel A; Yoshida, Sei et al. (2018) Loss of PTEN promotes formation of signaling-capable clathrin-coated pits. J Cell Sci 131:
Cilliers, Cornelius; Menezes, Bruna; Nessler, Ian et al. (2018) Improved Tumor Penetration and Single-Cell Targeting of Antibody-Drug Conjugates Increases Anticancer Efficacy and Host Survival. Cancer Res 78:758-768
Mendiratta-Lala, Mishal; Gu, Everett; Owen, Dawn et al. (2018) Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 102:1063-1069
Zhou, Bing; Hu, Jiantao; Xu, Fuming et al. (2018) Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. J Med Chem 61:462-481
Lorenz, Daniel A; Vander Roest, Steve; Larsen, Martha J et al. (2018) Development and Implementation of an HTS-Compatible Assay for the Discovery of Selective Small-Molecule Ligands for Pre-microRNAs. SLAS Discov 23:47-54
Chockley, Peter J; Chen, Jun; Chen, Guoan et al. (2018) Epithelial-mesenchymal transition leads to NK cell-mediated metastasis-specific immunosurveillance in lung cancer. J Clin Invest 128:1384-1396

Showing the most recent 10 out of 1493 publications